Global Injectable Drugs Market 2020-2030 by Molecule Type (Small, Large), Drug Class (mAbs, Immunoglobulin, Insulin, Vaccines, Cytokines, Peptide Hormone, Blood Factors), Delivery (Pre-filled Syringe, Infusions, Others), Application (Oncology, Infectious Diseases, Autoimmune, Cardiovascular), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Commerce), and Region: Trend Forecast and Growth Opportunity

November 2021 | 165 pages | ID: GC3395777A0AEN
GMD Research

Abstracts

Global injectable drugs market will reach $1,037.7 billion by 2030, growing by 9.8% annually over 2020-2030 driven by the increasing prevalence of chronic diseases, rising use of self-administered Injectable formulations, technological advancements in drug development, and growing approvals of new injectable drugs such as COVID-19 vaccines.

Highlighted with 82 tables and 86 figures, this 165-page report “Global Injectable Drugs Market 2020-2030 by Molecule Type (Small, Large), Drug Class (mAbs, Immunoglobulin, Insulin, Vaccines, Cytokines, Peptide Hormone, Blood Factors), Delivery (Pre-filled Syringe, Infusions, Others), Application (Oncology, Infectious Diseases, Autoimmune, Cardiovascular), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Commerce), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global injectable drugs market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year (Year 2020 is not appropriate for research base due to the outbreak of COVID-19).

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global injectable drugs market in every aspect of the classification from perspectives of Molecule Type, Drug Class, Delivery, Application, Distribution Channel, and Region.

Based on Molecule Type, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.

• Small Molecule
• Large Molecule

Based on Drug Class, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.

• Monoclonal Antibodies (mAbs)
• Immunoglobulin
• Insulin
• Vaccines
• Cytokines
• Peptide Hormone
• Blood Factors
• Other Drug Classes

Based on Delivery, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.

• Pre-filled Syringe
• Infusions
• Other Deliveries

Based on Application, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.

• Oncology
• Infectious Diseases
• Autoimmune Diseases
• Cardiovascular Diseases
• Pain
• Neurology
• Other Applications

Based on Distribution Channel, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.

• Hospital Pharmacy
• Retail Pharmacy
• E-Commerce

Geographically, the following regions together with the listed national/local markets are fully investigated:

• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa)

For each aforementioned region and country, detailed analysis and data for annual revenue ($ bn) are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Molecule Type, Drug Class, and Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Key Players (this may not be a complete list and extra companies can be added upon request):

Amgen Inc.

Baxter International Inc.

Eli Lilly and Company

Gilead Sciences Inc.

GlaxoSmithKline PLC

Johnson & Johnson

Merck & Co. Inc.

Moderna, Inc.

Novartis AG

Novo Nordisk AS

Pfizer Inc.

Sanofi SA

Teva Pharmaceuticals Industries Ltd.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF GLOBAL MARKET BY MOLECULE TYPE

3.1 Market Overview by Molecule Type
3.2 Small Molecule
3.3 Large Molecule

4 SEGMENTATION OF GLOBAL MARKET BY DRUG CLASS

4.1 Market Overview by Drug Class
4.2 Monoclonal Antibodies (mAbs)
4.3 Immunoglobulin
4.4 Insulin
4.5 Vaccines
4.6 Cytokines
4.7 Peptide Hormone
4.8 Blood Factors
4.9 Other Drug Classes

5 SEGMENTATION OF GLOBAL MARKET BY DELIVERY

5.1 Market Overview by Delivery
5.2 Pre-filled Syringe
5.3 Infusions
5.4 Other Deliveries

6 SEGMENTATION OF GLOBAL MARKET BY APPLICATION

6.1 Market Overview by Application
6.2 Oncology
6.3 Infectious Diseases
6.4 Autoimmune Diseases
6.5 Cardiovascular Diseases
6.6 Pain
6.7 Neurology
6.8 Other Applications

7 SEGMENTATION OF GLOBAL MARKET BY DISTRIBUTION CHANNEL

7.1 Market Overview by Distribution Channel
7.2 Hospital Pharmacy
7.3 Retail Pharmacy
7.4 E-Commerce

8 SEGMENTATION OF GLOBAL MARKET BY REGION

8.1 Geographic Market Overview 2019-2030
8.2 North America Market 2019-2030 by Country
  8.2.1 Overview of North America Market
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 European Market 2019-2030 by Country
  8.3.1 Overview of European Market
  8.3.2 Germany
  8.3.3 U.K.
  8.3.4 France
  8.3.5 Spain
  8.3.6 Italy
  8.3.7 Russia
  8.3.8 Rest of European Market
8.4 Asia-Pacific Market 2019-2030 by Country
  8.4.1 Overview of Asia-Pacific Market
  8.4.2 Japan
  8.4.3 China
  8.4.4 Australia
  8.4.5 India
  8.4.6 South Korea
  8.4.7 Rest of APAC Region
8.5 South America Market 2019-2030 by Country
  8.5.1 Argentina
  8.5.2 Brazil
  8.5.3 Chile
  8.5.4 Rest of South America Market
8.6 MEA Market 2019-2030 by Country
  8.6.1 UAE
  8.6.2 Saudi Arabia
  8.6.3 South Africa
  8.6.4 Other National Markets

9 COMPETITIVE LANDSCAPE

9.1 Overview of Key Vendors
9.2 New Product Launch, Partnership, Investment, and M&A
9.3 Company Profiles
Amgen Inc.
Baxter International Inc.
Eli Lilly and Company
Gilead Sciences Inc.
GlaxoSmithKline PLC
Johnson & Johnson
Merck & Co. Inc.
Moderna, Inc.
Novartis AG
Novo Nordisk AS
Pfizer Inc.
Sanofi SA
Teva Pharmaceuticals Industries Ltd.
RELATED REPORTS

List Of Tables

LIST OF TABLES:

Table 1. Snapshot of Global Injectable Drugs Market in Balanced Perspective, 2019-2030
Table 2. Growth Rate of World GDP, 2020-2022
Table 3. World Health Spending by Region, $ bn, 2013-2020
Table 4. Main Product Trends and Market Opportunities in Global Injectable Drugs Market
Table 5. Global Injectable Drugs Market by Molecule Type, 2019-2030, $ bn
Table 6. Global Injectable Drugs Market by Drug Class, 2019-2030, $ bn
Table 7. Global Injectable Drugs Market by Delivery, 2019-2030, $ bn
Table 8. Global Injectable Drugs Market by Application, 2019-2030, $ bn
Table 9. Global Injectable Drugs Market by Distribution Channel, 2019-2030, $ bn
Table 10. Global Injectable Drugs Market by Region, 2019-2030, $ bn
Table 11. Leading National Injectable Drugs Market, 2019 and 2030F, $ bn
Table 12. North America Injectable Drugs Market by Country, 2019-2030, $ bn
Table 13. U.S. Injectable Drugs Market by Molecule Type, 2019-2030, $ bn
Table 14. U.S. Injectable Drugs Market by Drug Class, 2019-2030, $ bn
Table 15. U.S. Injectable Drugs Market by Application, 2019-2030, $ bn
Table 16. Canada Injectable Drugs Market by Molecule Type, 2019-2030, $ bn
Table 17. Canada Injectable Drugs Market by Drug Class, 2019-2030, $ bn
Table 18. Canada Injectable Drugs Market by Application, 2019-2030, $ bn
Table 19. Mexico Injectable Drugs Market by Molecule Type, 2019-2030, $ bn
Table 20. Mexico Injectable Drugs Market by Drug Class, 2019-2030, $ bn
Table 21. Mexico Injectable Drugs Market by Application, 2019-2030, $ bn
Table 22. Europe Injectable Drugs Market by Country, 2019-2030, $ bn
Table 23. Germany Injectable Drugs Market by Molecule Type, 2019-2030, $ bn
Table 24. Germany Injectable Drugs Market by Drug Class, 2019-2030, $ bn
Table 25. Germany Injectable Drugs Market by Application, 2019-2030, $ bn
Table 26. U.K. Injectable Drugs Market by Molecule Type, 2019-2030, $ bn
Table 27. U.K. Injectable Drugs Market by Drug Class, 2019-2030, $ bn
Table 28. U.K. Injectable Drugs Market by Application, 2019-2030, $ bn
Table 29. France Injectable Drugs Market by Molecule Type, 2019-2030, $ bn
Table 30. France Injectable Drugs Market by Drug Class, 2019-2030, $ bn
Table 31. France Injectable Drugs Market by Application, 2019-2030, $ bn
Table 32. Spain Injectable Drugs Market by Molecule Type, 2019-2030, $ bn
Table 33. Spain Injectable Drugs Market by Drug Class, 2019-2030, $ bn
Table 34. Spain Injectable Drugs Market by Application, 2019-2030, $ bn
Table 35. Italy Injectable Drugs Market by Molecule Type, 2019-2030, $ bn
Table 36. Italy Injectable Drugs Market by Drug Class, 2019-2030, $ bn
Table 37. Italy Injectable Drugs Market by Application, 2019-2030, $ bn
Table 38. Russia Injectable Drugs Market by Molecule Type, 2019-2030, $ bn
Table 39. Russia Injectable Drugs Market by Drug Class, 2019-2030, $ bn
Table 40. Russia Injectable Drugs Market by Application, 2019-2030, $ bn
Table 41. Injectable Drugs Market in Rest of Europe by Country, 2019-2030, $ bn
Table 42. APAC Injectable Drugs Market by Country, 2019-2030, $ bn
Table 43. Japan Injectable Drugs Market by Molecule Type, 2019-2030, $ bn
Table 44. Japan Injectable Drugs Market by Drug Class, 2019-2030, $ bn
Table 45. Japan Injectable Drugs Market by Application, 2019-2030, $ bn
Table 46. China Injectable Drugs Market by Molecule Type, 2019-2030, $ bn
Table 47. China Injectable Drugs Market by Drug Class, 2019-2030, $ bn
Table 48. China Injectable Drugs Market by Application, 2019-2030, $ bn
Table 49. Australia Injectable Drugs Market by Molecule Type, 2019-2030, $ bn
Table 50. Australia Injectable Drugs Market by Drug Class, 2019-2030, $ bn
Table 51. Australia Injectable Drugs Market by Application, 2019-2030, $ bn
Table 52. India Injectable Drugs Market by Molecule Type, 2019-2030, $ bn
Table 53. India Injectable Drugs Market by Drug Class, 2019-2030, $ bn
Table 54. India Injectable Drugs Market by Application, 2019-2030, $ bn
Table 55. South Korea Injectable Drugs Market by Molecule Type, 2019-2030, $ bn
Table 56. South Korea Injectable Drugs Market by Drug Class, 2019-2030, $ bn
Table 57. South Korea Injectable Drugs Market by Application, 2019-2030, $ bn
Table 58. Injectable Drugs Market in Rest of APAC by Country/Region, 2019-2030, $ bn
Table 59. South America Injectable Drugs Market by Country, 2019-2030, $ bn
Table 60. Argentina Injectable Drugs Market by Molecule Type, 2019-2030, $ bn
Table 61. Argentina Injectable Drugs Market by Drug Class, 2019-2030, $ bn
Table 62. Argentina Injectable Drugs Market by Application, 2019-2030, $ bn
Table 63. Brazil Injectable Drugs Market by Molecule Type, 2019-2030, $ bn
Table 64. Brazil Injectable Drugs Market by Drug Class, 2019-2030, $ bn
Table 65. Brazil Injectable Drugs Market by Application, 2019-2030, $ bn
Table 66. Chile Injectable Drugs Market by Molecule Type, 2019-2030, $ bn
Table 67. Chile Injectable Drugs Market by Drug Class, 2019-2030, $ bn
Table 68. Chile Injectable Drugs Market by Application, 2019-2030, $ bn
Table 69. MEA Injectable Drugs Market by Country, 2019-2030, $ bn
Table 70. UAE Injectable Drugs Market by Molecule Type, 2019-2030, $ bn
Table 71. UAE Injectable Drugs Market by Drug Class, 2019-2030, $ bn
Table 72. UAE Injectable Drugs Market by Application, 2019-2030, $ bn
Table 73. Saudi Arabia Injectable Drugs Market by Molecule Type, 2019-2030, $ bn
Table 74. Saudi Arabia Injectable Drugs Market by Drug Class, 2019-2030, $ bn
Table 75. Saudi Arabia Injectable Drugs Market by Application, 2019-2030, $ bn
Table 76. South Africa Injectable Drugs Market by Molecule Type, 2019-2030, $ bn
Table 77. South Africa Injectable Drugs Market by Drug Class, 2019-2030, $ bn
Table 78. South Africa Injectable Drugs Market by Application, 2019-2030, $ bn
Table 79. Amgen Inc.: Company Snapshot
Table 80. Amgen Inc.: Business Segmentation
Table 81. Amgen Inc.: Product Portfolio
Table 82. Amgen Inc.: Revenue, 2018-2020, $ bn

List Of Figures

LIST OF FIGURES:

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030
Figure 4. Global Injectable Drugs Market, 2019-2030, $ bn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Global Injectable Drugs Market
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060
Figure 9. Primary Restraints and Impact Factors of Global Injectable Drugs Market
Figure 10. Investment Opportunity Analysis
Figure 11. Porter’s Fiver Forces Analysis of Global Injectable Drugs Market
Figure 12. Breakdown of Global Injectable Drugs Market by Molecule Type, 2019-2030, % of Revenue
Figure 13. Global Addressable Market Cap in 2021-2030 by Molecule Type, Value ($ bn) and Share (%)
Figure 14. Global Injectable Drugs Market by Molecule Type: Small Molecule, 2019-2030, $ bn
Figure 15. Global Injectable Drugs Market by Molecule Type: Large Molecule, 2019-2030, $ bn
Figure 16. Breakdown of Global Injectable Drugs Market by Drug Class, 2019-2030, % of Sales Revenue
Figure 17. Global Addressable Market Cap in 2021-2030 by Drug Class, Value ($ bn) and Share (%)
Figure 18. Global Injectable Drugs Market by Drug Class: Monoclonal Antibodies (mAbs), 2019-2030, $ bn
Figure 19. Global Injectable Drugs Market by Drug Class: Immunoglobulin, 2019-2030, $ bn
Figure 20. Global Injectable Drugs Market by Drug Class: Insulin, 2019-2030, $ bn
Figure 21. Global Injectable Drugs Market by Drug Class: Vaccines, 2019-2030, $ bn
Figure 22. Global Injectable Drugs Market by Drug Class: Cytokines, 2019-2030, $ bn
Figure 23. Global Injectable Drugs Market by Drug Class: Peptide Hormone, 2019-2030, $ bn
Figure 24. Global Injectable Drugs Market by Drug Class: Blood Factors, 2019-2030, $ bn
Figure 25. Global Injectable Drugs Market by Drug Class: Other Drug Classes, 2019-2030, $ bn
Figure 26. Breakdown of Global Injectable Drugs Market by Delivery, 2019-2030, % of Sales Revenue
Figure 27. Global Addressable Market Cap in 2021-2030 by Delivery, Value ($ bn) and Share (%)
Figure 28. Global Injectable Drugs Market by Delivery: Pre-filled Syringe, 2019-2030, $ bn
Figure 29. Global Injectable Drugs Market by Delivery: Infusions, 2019-2030, $ bn
Figure 30. Global Injectable Drugs Market by Delivery: Other Deliveries, 2019-2030, $ bn
Figure 31. Breakdown of Global Injectable Drugs Market by Application, 2019-2030, % of Revenue
Figure 32. Global Addressable Market Cap in 2021-2030 by Application, Value ($ bn) and Share (%)
Figure 33. Global Injectable Drugs Market by Application: Oncology, 2019-2030, $ bn
Figure 34. Global Injectable Drugs Market by Application: Infectious Diseases, 2019-2030, $ bn
Figure 35. Global Injectable Drugs Market by Application: Autoimmune Diseases, 2019-2030, $ bn
Figure 36. Global Injectable Drugs Market by Application: Cardiovascular Diseases, 2019-2030, $ bn
Figure 37. Global Injectable Drugs Market by Application: Pain, 2019-2030, $ bn
Figure 38. Global Injectable Drugs Market by Application: Neurology, 2019-2030, $ bn
Figure 39. Global Injectable Drugs Market by Application: Other Applications, 2019-2030, $ bn
Figure 40. Breakdown of Global Injectable Drugs Market by Distribution Channel, 2019-2030, % of Revenue
Figure 41. Global Addressable Market Cap in 2021-2030 by Distribution Channel, Value ($ bn) and Share (%)
Figure 42. Global Injectable Drugs Market by Distribution Channel: Hospital Pharmacy, 2019-2030, $ bn
Figure 43. Global Injectable Drugs Market by Distribution Channel: Retail Pharmacy, 2019-2030, $ bn
Figure 44. Global Injectable Drugs Market by Distribution Channel: E-Commerce, 2019-2030, $ bn
Figure 45. Global Market Snapshot by Region
Figure 46. Geographic Spread of Worldwide Injectable Drugs Market, 2019-2030, % of Sales Revenue
Figure 47. Global Addressable Market Cap in 2021-2030 by Region, Value ($ bn) and Share (%)
Figure 48. North American Injectable Drugs Market, 2019-2030, $ bn
Figure 49. Breakdown of North America Injectable Drugs Market by Country, 2019 and 2030, % of Revenue
Figure 50. Contribution to North America 2021-2030 Cumulative Market by Country, Value ($ bn) and Share (%)
Figure 51. U.S. Injectable Drugs Market, 2019-2030, $ bn
Figure 52. Canada Injectable Drugs Market, 2019-2030, $ bn
Figure 53. Injectable Drugs Market in Mexico, 2019-2030, $ bn
Figure 54. European Injectable Drugs Market, 2019-2030, $ bn
Figure 55. Breakdown of European Injectable Drugs Market by Country, 2019 and 2030, % of Revenue
Figure 56. Contribution to Europe 2021-2030 Cumulative Market by Country, Value ($ bn) and Share (%)
Figure 57. Injectable Drugs Market in Germany, 2019-2030, $ bn
Figure 58. Injectable Drugs Market in U.K., 2019-2030, $ bn
Figure 59. Injectable Drugs Market in France, 2019-2030, $ bn
Figure 60. Injectable Drugs Market in Spain, 2019-2030, $ bn
Figure 61. Injectable Drugs Market in Italy, 2019-2030, $ bn
Figure 62. Injectable Drugs Market in Russia, 2019-2030, $ bn
Figure 63. Injectable Drugs Market in Rest of Europe, 2019-2030, $ bn
Figure 64. Asia-Pacific Injectable Drugs Market, 2019-2030, $ bn
Figure 65. Breakdown of APAC Injectable Drugs Market by Country, 2019 and 2030, % of Revenue
Figure 66. Contribution to APAC 2021-2030 Cumulative Market by Country, Value ($ bn) and Share (%)
Figure 67. Injectable Drugs Market in Japan, 2019-2030, $ bn
Figure 68. Injectable Drugs Market in China, 2019-2030, $ bn
Figure 69. Injectable Drugs Market in Australia, 2019-2030, $ bn
Figure 70. Injectable Drugs Market in India, 2019-2030, $ bn
Figure 71. Injectable Drugs Market in South Korea, 2019-2030, $ bn
Figure 72. Injectable Drugs Market in Rest of APAC, 2019-2030, $ bn
Figure 73. South America Injectable Drugs Market, 2019-2030, $ bn
Figure 74. Breakdown of South America Injectable Drugs Market by Country, 2019 and 2030, % of Revenue
Figure 75. Contribution to South America 2021-2030 Cumulative Market by Country, Value ($ bn) and Share (%)
Figure 76. Injectable Drugs Market in Argentina, 2019-2030, $ bn
Figure 77. Injectable Drugs Market in Brazil, 2019-2030, $ bn
Figure 78. Injectable Drugs Market in Chile, 2019-2030, $ bn
Figure 79. Injectable Drugs Market in Rest of South America, 2019-2030, $ bn
Figure 80. Injectable Drugs Market in Middle East and Africa (MEA), 2019-2030, $ bn
Figure 81. Breakdown of MEA Injectable Drugs Market by Country, 2019 and 2030, % of Revenue
Figure 82. Contribution to MEA 2021-2030 Cumulative Market by Country, Value ($ bn) and Share (%)
Figure 83. Injectable Drugs Market in UAE, 2019-2030, $ bn
Figure 84. Injectable Drugs Market in Saudi Arabia, 2019-2030, $ bn
Figure 85. Injectable Drugs Market in South Africa, 2019-2030, $ bn
Figure 86. Growth Stage of Global Injectable Drugs Industry over the Forecast Period